Last $45.53 USD
Change Today +0.10 / 0.22%
Volume 1.1M
NVO On Other Exchanges
Symbol
Exchange
OTC US
Copenhagen
New York
Frankfurt
Frankfurt
As of 8:04 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jesper Brandgaard MSc

Chief Financial Officer, Executive Vice President, Chairman of the Board - Novo Nordisk Engineering A/S and Chairman of the Board - Novo Nordisk IT A/S, Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 27 board members in 3 different organizations across 4 different industries.

See Board Relationships
51kr10,400,000
As of Fiscal Year 2013

Background*

Mr. Jesper Brandgaard, MSc has been the Chief Financial Officer and Executive Vice President of Novo Nordisk A/S since November 2000 and served as its Member of Senior Management Board. Mr. Brandgaard joined Novo Nordisk A/S in 1999 as a senior Vice President of Finance. He served as the Chairman of the Board at NNE Pharmaplan A/S (formerly, Novo Nordisk Engineering A/s) and Novo Nordisk IT A/S, subsidiaries of Novo Nordisk A/S. He has been the Chairman of NNIT A/S since ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880

Denmark

Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

Former Chairman
2002-Present
Chairman of the Board
2007-Present
Chairman

Education*

MS 1990
Copenhagen Business School
MBA 1995
Copenhagen Business School

Other Affiliations*

Annual Compensation*

Salarykr5,700,000
Bonuskr2,400,000
Total Annual Compensationkr8,100,000

Stock Options*

All Other Compensationkr2,300,000

Total Compensation*

Total Annual Cash Compensationkr10,400,000
Total Short Term Compensationkr8,100,000
Other Long Term Compensationkr2,300,000
Total Calculated Compensationkr10,400,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVO:US $45.53 USD +0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO-NORDISK A/S-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.